83 related articles for article (PubMed ID: 26183340)
1. Pattern recognition of monocyte chemoattractant protein-1 (MCP-1) in whole blood samples using new platforms based on nanostructured materials.
Stefan-van Staden RI; Gugoasa LA; Biris AR
Nanoscale; 2015 Sep; 7(36):14848-53. PubMed ID: 26183340
[TBL] [Abstract][Full Text] [Related]
2. Molecular recognition of HER-1 in whole-blood samples.
Moldoveanu I; Stanciu Gavan C; Stefan-van Staden RI
J Mol Recognit; 2014 Nov; 27(11):653-8. PubMed ID: 25277089
[TBL] [Abstract][Full Text] [Related]
3. A graphene-based Au(111) platform for electrochemical biosensing based catalytic recycling of products on gold nanoflowers.
Liu B; Tang D; Tang J; Su B; Li Q; Chen G
Analyst; 2011 Jun; 136(11):2218-20. PubMed ID: 21384013
[TBL] [Abstract][Full Text] [Related]
4. Pattern recognition of neuron specific enolase and carcinoembryonic antigen in whole blood samples.
Stefan-van Staden RI; Comnea-Stancu IR; Surdu-Bob CC; Stanciu-Gavan C
J Mol Recognit; 2015 Feb; 28(2):103-7. PubMed ID: 25604868
[TBL] [Abstract][Full Text] [Related]
5. Pattern recognition of HER-1 in biological fluids using stochastic sensing.
Stefan-van Staden RI; Moldoveanu I; Gavan CS
J Enzyme Inhib Med Chem; 2015 Apr; 30(2):283-5. PubMed ID: 24964343
[TBL] [Abstract][Full Text] [Related]
6. Systemic monocyte chemoattractant protein-1 concentrations are independent of type 2 diabetes or parameters of obesity: results from the Cooperative Health Research in the Region of Augsburg Survey S4 (KORA S4).
Herder C; Müller-Scholze S; Rating P; Koenig W; Thorand B; Haastert B; Holle R; Illig T; Rathmann W; Seissler J; Wichmann HE; Kolb H
Eur J Endocrinol; 2006 Feb; 154(2):311-7. PubMed ID: 16452546
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acid functionalized graphene for biosensing.
Bonanni A; Ambrosi A; Pumera M
Chemistry; 2012 Feb; 18(6):1668-73. PubMed ID: 22213459
[TBL] [Abstract][Full Text] [Related]
8. Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Kim CS; Park HS; Kawada T; Kim JH; Lim D; Hubbard NE; Kwon BS; Erickson KL; Yu R
Int J Obes (Lond); 2006 Sep; 30(9):1347-55. PubMed ID: 16534530
[TBL] [Abstract][Full Text] [Related]
9. Stochastic microsensors based on modified graphene for pattern recognition of maspin in biological samples.
Stefan-van Staden RI; Bogea IM; Ilie-Mihai RM; Gheorghe DC; Coroş M; Pruneanu SM
Anal Bioanal Chem; 2022 May; 414(12):3667-3673. PubMed ID: 35266021
[TBL] [Abstract][Full Text] [Related]
10. Pattern recognition of neurotransmitters using multimode sensing.
Stefan-van Staden RI; Moldoveanu I; van Staden JF
J Neurosci Methods; 2014 May; 229():1-7. PubMed ID: 24680958
[TBL] [Abstract][Full Text] [Related]
11. Hierarchical nanostructured noble metal/metal oxide/graphene-coated carbon fiber: in situ electrochemical synthesis and use as microelectrode for real-time molecular detection of cancer cells.
Abdurhman AA; Zhang Y; Zhang G; Wang S
Anal Bioanal Chem; 2015 Oct; 407(26):8129-36. PubMed ID: 26359235
[TBL] [Abstract][Full Text] [Related]
12. Pattern recognition of 8-hydroxy-2'-deoxyguanosine in biological fluids.
Stefan-van Staden RI; Balahura LR; Gugoasa LA; van Staden JF; Aboul-Enein HY; Rosu MC; Pruneanu SM
Anal Bioanal Chem; 2018 Jan; 410(1):115-121. PubMed ID: 29067480
[TBL] [Abstract][Full Text] [Related]
13. Monocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity study.
Chacón MR; Fernández-Real JM; Richart C; Megía A; Gómez JM; Miranda M; Caubet E; Pastor R; Masdevall C; Vilarrasa N; Ricard W; Vendrell J
Obesity (Silver Spring); 2007 Mar; 15(3):664-72. PubMed ID: 17372317
[TBL] [Abstract][Full Text] [Related]
14. Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects.
Rosenson RS; Tangney CC; Levine DM; Parker TS; Gordon BR
J Lab Clin Med; 2005 Feb; 145(2):83-7. PubMed ID: 15746650
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of an immunosensor for monocyte chemotactic protein 1 using a silicon photonic microring resonator biosensing platform.
Valera E; Shia WW; Bailey RC
Clin Biochem; 2016 Jan; 49(1-2):121-6. PubMed ID: 26365696
[TBL] [Abstract][Full Text] [Related]
16. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men.
Fu CP; Lee IT; Sheu WH; Lee WJ; Liang KW; Lee WL; Lin SY
Clin Chim Acta; 2012 Oct; 413(19-20):1647-51. PubMed ID: 22609259
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of monocyte chemoattractant protein-1 in healthy and critically ill dogs.
Duffy AL; Olea-Popelka FJ; Eucher J; Rice DM; Dow SW
Vet Clin Pathol; 2010 Sep; 39(3):302-5. PubMed ID: 20412549
[TBL] [Abstract][Full Text] [Related]
18. Plasma monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1alpha are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment.
Glintborg D; Andersen M; Richelsen B; Bruun JM
Clin Endocrinol (Oxf); 2009 Nov; 71(5):652-8. PubMed ID: 19170716
[TBL] [Abstract][Full Text] [Related]
19. An enzymeless organophosphate pesticide sensor using Au nanoparticle-decorated graphene hybrid nanosheet as solid-phase extraction.
Gong J; Miao X; Zhou T; Zhang L
Talanta; 2011 Sep; 85(3):1344-9. PubMed ID: 21807193
[TBL] [Abstract][Full Text] [Related]
20. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.
de Lemos JA; Morrow DA; Blazing MA; Jarolim P; Wiviott SD; Sabatine MS; Califf RM; Braunwald E
J Am Coll Cardiol; 2007 Nov; 50(22):2117-24. PubMed ID: 18036447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
